Date published: 2025-11-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

CD79B Activators

CD79B, in conjunction with CD79A, constitutes an indispensable component of the B-cell receptor (BCR) complex, essential for the transduction of signals necessary for B-cell activation, development, and differentiation. This heterodimer acts as a pivotal conduit for conveying extracellular antigen recognition signals to the intracellular signaling apparatus of B-cells, thereby initiating a cascade of events leading to B-cell proliferation, antibody production, and the establishment of immunological memory. The function of CD79B extends beyond mere signal transduction; it is crucial for the surface expression of the BCR complex, ensuring that B-cells are capable of responding to antigens with high sensitivity and specificity. This sensitivity is paramount for the adaptive immune system's ability to identify and neutralize a vast array of pathogens, highlighting CD79B's role in maintaining the immunological repertoire and safeguarding organismal health.

The activation of CD79B is intricately linked to its phosphorylation status, which occurs upon antigen binding to the BCR, triggering a series of phosphorylation events on the immunoreceptor tyrosine-based activation motifs (ITAMs) present in the cytoplasmic tails of CD79B. This phosphorylation serves as a critical signal for the recruitment and activation of downstream signaling molecules, including Syk kinase, which further propagates the signal through various pathways, such as PLCγ2, leading to calcium mobilization, cytoskeletal reorganization, and transcriptional activation of genes involved in B-cell proliferation and differentiation. Moreover, the modulation of CD79B activity and its expression levels are finely tuned by the cellular context, ensuring that B-cell activation is appropriately regulated in response to immunological challenges. This regulation involves a complex interplay of co-stimulatory signals and inhibitory checkpoints that ensure the immune response is effective against pathogens. Understanding the mechanisms underlying CD79B activation offers profound insights into the orchestration of B-cell functions and the broader dynamics of the immune response.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a potent inhibitor of phosphatidylinositol 3-kinase (PI3K). Inhibition of PI3K can indirectly influence CD79B activity by affecting the PI3K/AKT signaling pathway, involved in B cell receptor (BCR) signaling.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin is an mTOR inhibitor. By inhibiting mTOR, it can indirectly affect CD79B activity through the PI3K/AKT/mTOR pathway, which is involved in BCR signaling.

Stat3 Inhibitor VI, S3I-201

501919-59-1sc-204304
10 mg
$148.00
104
(1)

S3I-201 is an inhibitor of STAT3. By inhibiting STAT3, it can indirectly influence CD79B activity through the JAK/STAT signaling pathway, which is connected to BCR signaling.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 is a JNK inhibitor. By inhibiting JNK, it can indirectly influence CD79B activity through the JNK signaling pathway, which is involved in BCR signaling.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

SB203580 is an inhibitor of p38 MAPK. By inhibiting p38 MAPK, it can indirectly affect CD79B activity through the p38 MAPK signaling pathway, which is connected to BCR signaling.

Pyrrolidinedithiocarbamic acid ammonium salt

5108-96-3sc-203224
sc-203224A
5 g
25 g
$32.00
$63.00
11
(1)

PDTC is an NF-κB inhibitor. By inhibiting NF-κB, it can indirectly influence CD79B activity through the NF-κB signaling pathway, which is involved in BCR signaling.

Tyrphostin B42

133550-30-8sc-3556
5 mg
$26.00
4
(1)

Tyrphostin B42 is a JAK2 inhibitor. By inhibiting JAK2, it can indirectly influence CD79B activity through the JAK/STAT signaling pathway, which is connected to BCR signaling.

BAY 11-7082

19542-67-7sc-200615B
sc-200615
sc-200615A
5 mg
10 mg
50 mg
$61.00
$83.00
$349.00
155
(1)

BAY 11-7082 is an NF-κB inhibitor. By inhibiting NF-κB, it can indirectly influence CD79B activity through the NF-κB signaling pathway, which is involved in BCR signaling.

PP 2

172889-27-9sc-202769
sc-202769A
1 mg
5 mg
$92.00
$223.00
30
(1)

PP2 is an Src family tyrosine kinases inhibitor. By inhibiting Src family tyrosine kinases, it can indirectly influence CD79B activity through the Src family kinases pathway, which is connected to BCR signaling.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Wortmannin is a potent phosphoinositide 3-kinase (PI3K) inhibitor. By inhibiting PI3K, it can indirectly influence CD79B activity through the PI3K/AKT signaling pathway, which is involved in BCR signaling.